Healthcare

SINGAPORE (Sept 21): Cennerv Pharmaceuticals on Wednesday lodged its preliminary prospectus ahead of its planned initial public offering (IPO) on the SGX Catalist board.

SINGAPORE (Sept 21): Singapore, grappling with an aging population and a shortage of high-tech workers, says it needs to bring in foreign talent in areas including software programming while the country rebalances its education system to meet future deman

SINGAPORE/JAKARTA (Sept 19): Southeast Asia’s billionaire Riady family is reshuffling its health-care holdings as its core property business grapples with the emerging-market rout.

SINGAPORE (Aug 28): Health Management International (HMI) reported earnings of RM15.2 million ($5.1 million) for the 4Q ended June, up 43% y-o-y from RM10.7 million a year ago on higher revenue and improved margins.

SINGAPORE (Aug 23): Clearbridge Health’s wholly-owned subsidiary, SAM Laboratory, is acquiring a controlling stake in PT Indo Genesis Medika, a company incorporated in Indonesia, for an aggregate consideration of about IDR 40.7 billion ($3.8 million).

SINGAPORE (Aug 20): Changes to government schemes on healthcare and housing were outlined by Prime Minister Lee Hsien Loong in his National Day Rally speech on Sunday night.

SINGAPORE (Aug 6): When K Leela, 68, was diagnosed with kidney failure about a decade ago, she panicked about the cost. The homemaker needs to have dialysis at least twice a week, for life. Her husband works as a hotel bellhop, and they have three childre

SINGAPORE (July 13): Acromec has secured a contract valued at $2.9 million for the outfitting of a private day-surgery centre.

SINGAPORE (July 11): UOB Kay Hian is starting Asian Healthcare Specialists (AHS) at “buy” with a target price of 33 cents as it views the stock as a proxy to increased medical spending from Singapore’s ageing population and rising participation in s

SINGAPORE (June 28): Clearbridge BioMedics has announced $6.6 million in pre-initial public offering (IPO) funding from oncology medical professionals, as well as investors focused in healthcare & biotechnology.